The Partners Value Fund’s Investor Class returned -1.4% in the third calendar quarter, compared to a +1.1% return for the S&P 500 and flat results for the Russell 3000. The largest companies were generally the strongest performers in the third quarter, most notably Microsoft (MSFT) (+12%), Berkshire Hathaway (BRK.B) (+9%) and Valeant Pharmaceuticals (VRX) (+4%) for our Fund. Conversely, small cap stocks fell sharply in July and again in September, with the Russell 2000 index finishing down 7.4% for the quarter. While smaller companies account for approximately 10% of our net assets, these stocks drove most of the Fund’s quarterly decline. Iconix Brand Group (ICON) (-14%), Redwood Trust (RWT) (-14%) and Interval Leisure Group (IILG) (-13%) were the primary small cap detractors. Energy holdings Range Resources (RRC) (-22%) and Apache (APA) (-6%) also impacted results as natural gas and oil prices dropped. We remain optimistic on the long-term outlooks for all five of these stocks, which trade at moderate to large discounts to our business value estimates.
For the calendar year-to-date, the Fund’s Investor Class returned +2.9% compared to +8.3% for the S&P 500 and +7.0% for the Russell 3000. DIRECTV (DTV) (+25% on AT&T’s buyout offer), Martin Marietta Materials (MLM) (+30% on its acquisition of Texas Industries) and Valeant Pharmaceuticals (VRX) (+12%, and in the news for its hostile takeover battle for Allergan) benefited from the robust deal environment in different ways. Interval Leisure (IILG) (-37%) was the largest detractor and one of our few companies where business value declined. Our earnings estimates fell roughly 15% when Interval announced that four large, multi-year corporate relationships renewed at less favorable rates in their timeshare exchange business. We think the stock has overreacted to this news, and the company continues to add strategically to its platform. Other small-cap stocks that detracted from year-to-date results included XO Group (XOXO) (-25%) and Redwood Trust (RWT) (-11%). Broader themes behind the relative shortfall include our overweight position in consumer discretionary companies (the weakest sector in the market year-to-date), our lack of near-term big winners in health care and technology (the strongest sectors in the market year-to-date) and our conservative portfolio positioning in the first half of the year. We are not pleased with recent results. It is natural for our concentrated investing style to be out of step with the market at times.
We bought relatively small new positions in Willis Group Holdings and Avon Products in the third quarter. Willis (WSH) is a leading global insurance broker. We have followed this attractive industry for many years through investments in Aon, Brown & Brown and others (including Willis under prior management). Organic revenue growth has been solid, and Willis has a near-term opportunity to expand margins through expense initiatives and restructuring savings that are likely to kick in next year. We think the stock should be revalued higher once management follows through on its pledged cost discipline and drives operating leverage. Avon (AVP) is a direct selling, branded beauty business undergoing a turnaround in the U.S. market. The overwhelming majority of Avon’s business value comes from its stronger positions in Latin America and other emerging markets. Our investment thesis is that well-run direct selling can be a decent business with solid margins and high returns, that the Avon brand is not fundamentally broken, and that the U.S. business is bottoming as evidenced by break-even results in the most recent quarter. Avon has a wider range of potential outcomes than our typical investment and is sized accordingly.
In other portfolio activity we added to Liberty Global (LBTYA) after a helpful meeting with management, topped up our Valeant (VRX) position when the stock weakened during the summer, and modestly trimmed Iconix (ICON) shares with the stock in the $40’s. We also sold Target (TGT) at a healthy gain as new management works through several operational challenges against a tough competitive backdrop. On balance we were net buyers, with residual cash declining from 28% to 24% of net assets at quarter end.
We have a sizeable on-deck list of companies that we would like to own. As business values grind higher and many stock prices tread water or decline, our opportunity set grows. At a minimum, we have more candidates for recycling capital out of more expensive stocks into cheaper, higher conviction holdings. We already have added one new company to the Fund in the first weeks of the fourth quarter, with several others under active discussion. More price volatility would likely drive additional portfolio activity. We look forward to updating you on our progress at year end.
Partners Value is a flexible, multi-cap fund that invests in companies of all sizes. The portfolio remains tilted to larger companies with strong competitive positions, relatively stable cash flows, able managements and sturdy balance sheets. Nearly seventy percent of the Fund’s equity holdings are in large-cap companies (market capitalization greater than $10B), with the remainder split between medium-sized and smaller businesses.
Fund Performance
Click here to see our Full Performance Summary, including current to the most recent month end. The performance numbers above reflect the deduction of the Fund's Institutional Class annual operating expenses which as stated in its most recent Prospectus are 1.08% (estimated gross) and 0.99% (estimated net) of the Fund's Institutional Class net assets. The returns assume redemption at the end of each period and reinvestment of dividends. Total returns show include fee waivers and expense reimbursements, if any; total returns would have been lower had there been no waiver of fees and/or reimbursements of expenses by the Adviser. This information represents past performance and past performance does not guarantee future results. The investment return and the principal value of an investment in the Fund will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. Current performance may be higher or lower than the performance data quoted above.
